Literature DB >> 19169405

HIV-associated lymphoma.

Mala Karunanayake1, Carol Adair.   

Abstract

Entities:  

Year:  2009        PMID： 19169405      PMCID： PMC2626365          DOI： 10.1080/08998280.2009.11928478

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN： 0899-8280


× No keyword cloud information.
  13 in total

1.  Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus.

Authors:  R G Nador; E Cesarman; A Chadburn; D B Dawson; M Q Ansari; J Sald; D M Knowles
Journal:  Blood       Date:  1996-07-15       Impact factor: 22.113

2.  Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS.

Authors:  Emmanuelle Boulanger; Laurence Gérard; Jean Gabarre; Jean-Michel Molina; Christophe Rapp; Jean-François Abino; Jacques Cadranel; Sylvie Chevret; Eric Oksenhendler
Journal:  J Clin Oncol       Date:  2005-07-01       Impact factor: 44.544

3.  Complete remission of a primary effusion lymphoma with antiretroviral therapy.

Authors:  E Oksenhendler; J P Clauvel; S Jouveshomme; F Davi; G Mansour
Journal:  Am J Hematol       Date:  1998-03       Impact factor: 10.047

4.  Mechanisms of growth control of Kaposi's sarcoma-associated herpes virus-associated primary effusion lymphoma cells.

Authors:  H Asou; J W Said; R Yang; R Munker; D J Park; N Kamada; H P Koeffler
Journal:  Blood       Date:  1998-04-01       Impact factor: 22.113

5.  Involvement of interleukin-10 (IL-10) and viral IL-6 in the spontaneous growth of Kaposi's sarcoma herpesvirus-associated infected primary effusion lymphoma cells.

Authors:  K D Jones; Y Aoki; Y Chang; P S Moore; R Yarchoan; G Tosato
Journal:  Blood       Date:  1999-10-15       Impact factor: 22.113

6.  Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases.

Authors:  Erich J Schwartz; Ronald F Dorfman; Sabine Kohler
Journal:  Am J Surg Pathol       Date:  2003-12       Impact factor: 6.394

7.  Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas.

Authors:  J An; Y Sun; M Fisher; M B Rettig
Journal:  Leukemia       Date:  2004-10       Impact factor: 11.528

8.  Combined chemotherapy including high-dose methotrexate in KSHV/HHV8-associated primary effusion lymphoma.

Authors:  Emmanuelle Boulanger; Marie-Thérèse Daniel; Félix Agbalika; Eric Oksenhendler
Journal:  Am J Hematol       Date:  2003-07       Impact factor: 10.047

Review 9.  Primary effusion lymphoma.

Authors:  Yi-Bin Chen; Aliyah Rahemtullah; Ephraim Hochberg
Journal:  Oncologist       Date:  2007-05

10.  Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study.

Authors:  Cecelia Simonelli; Michele Spina; Roberta Cinelli; Renato Talamini; Rosamaria Tedeschi; Annunziata Gloghini; Emanuela Vaccher; Antonio Carbone; Umberto Tirelli
Journal:  J Clin Oncol       Date:  2003-11-01       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.